Image
Explore the key conclusions around aiming for higher treatment targets, discussed at the UCB-sponsored Satellite Symposium presented at EULAR 2023.
Back to top
Prof Brian Kirby
Consultant Dermatologist
Professor Brian Kirby is Consultant Dermatologist at St Vincent’s University Hospital, Dublin, Ireland, and Full Clinical Professor at University College Dublin, Ireland.
Professor Kirby’s clinical and research interests include psoriasis and hidradenitis suppurativa. He is co-Chair of the Dublin Hidradenitis Suppurativa Research Group and a Principal Investigator at the Charles Institute of Dermatology at University College Dublin.
Professor Kirby is also a former member of the steering committee of British Association of Dermatologists Biologics and Immunomodulatory Register (BADBIR), a member of the International Psoriasis Council (IPC), a member of the scientific committee of the European Hidradenitis Suppurativa Foundation (EHSF) and Chairperson of the Clinical Advisory Group of Dermatology at the Royal College of Physicians of Ireland.
He has authored or co-authored more than 250 publications, the majority of which are on psoriasis and hidradenitis suppurativa. Additionally, he is Associate Editor of the British Journal of Dermatology and Dermatology.
0 resources
You are currently seeing only Rheumatology content
Video3 minutes watch
Watch Prof Lars Erik Kristensen and Prof Frank Behrens discuss how MDA is a realistic treatment target in clinical practice and the barriers to achieving it for...
EU-DA-2400669
Video2 minutes watch
Treatment for PsA should target a broad range of musculoskeletal and extra-articular manifestations.1 Listen to Assoc. Prof Philipp Sewerin explain how MDA can...
EU-DA-2400668
Video2 minutes watch
axSpA is a complex disease with a significant burden on many aspects of daily life.1,2 Dive into the importance of ASAS40 for your patients with Dr Fabian Proft.
EU-DA-2400666
Video1 minute watch
Watch Prof Robert Landewé discuss the importance of using ASDAS <2.1 as a treatment target for patients with axSpA.
EU-DA-2400662
Article3 minutes read
Read our key takeaways from the 2022 ASAS-EULAR recommendations for the management of axSpA, presented as part of Dr Sofia Ramiro's workshop at UCB Summit 2023.
EU-DA-2400660